Compare PTCT & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | OSIS |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.2B |
| IPO Year | 2013 | 1997 |
| Metric | PTCT | OSIS |
|---|---|---|
| Price | $77.48 | $265.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | $73.76 | ★ $268.67 |
| AVG Volume (30 Days) | ★ 2.3M | 338.4K |
| Earning Date | 11-04-2025 | 01-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.72 |
| EPS | ★ 8.94 | 8.81 |
| Revenue | ★ $1,779,150,000.00 | $1,753,782,000.00 |
| Revenue This Year | $128.32 | $9.62 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | ★ $8.64 | $30.18 |
| Revenue Growth | ★ 97.54 | 9.37 |
| 52 Week Low | $35.95 | $150.84 |
| 52 Week High | $87.50 | $292.34 |
| Indicator | PTCT | OSIS |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 51.38 |
| Support Level | $73.03 | $264.78 |
| Resistance Level | $79.03 | $275.65 |
| Average True Range (ATR) | 3.38 | 12.05 |
| MACD | -0.70 | 0.17 |
| Stochastic Oscillator | 29.37 | 77.93 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.